BioHarvest Sciences Inc.
corporate_fare Company Profile
BioHarvest Sciences Inc. (NASDAQ:BHST) is a publicly traded company in the Life Sciences sector. Wiseek monitors BHST SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- BioHarvest Lands $1.4M Non-Dilutive Grant for AI-Driven Plant-Cell R&D
- BioHarvest Sciences to Present at BIO International Convention, Seeking Partnerships
- Tate & Lyle Expands BioHarvest Sciences Partnership for Next-Gen Sweetener Innovation
- Q1 2026 Revenue Up 8% to $8.5M, Net Loss Widens to $2.6M; CDMO Projects Advance
- Q1 2026 Results Show Increased Net Loss and Going Concern Warning Despite Improved Working Capital
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BHST, detected from its recent SEC filings · based on capital-structure filings through 2026-07-15.
$1.4M IIA Grant Formalized · Second IIA Grant in 2026
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BHST files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.